The gene-editing technology known as CRISPR has led to revolutionary changes in agriculture, health research and more.
NIH funding for phased clinical trials represents <3.5% of total spending
The U.S. National Institutes of Health (NIH) contributed $8.1 billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019,